Literature DB >> 27082064

We Lower Blood Flow for Intradialytic Hypotension.

Richard A Sherman1.   

Abstract

Whether hemodialysis is performed through a fistula, graft, or a dialysis catheter, it is a common practice to lower the dialyzer blood flow in patients who develop intradialytic hypotension. Lowering dialyzer blood flow is assumed to reduce AV access blood flow and thus increase peripheral vascular resistance tending to raise blood pressure. As a general rule, however, such a reduction in dialyzer blood flow does not lower access flow; only in the case of an intra-access stenosis could this be the case. Reducing access blood flow (in both catheter and AV accesses) did ameliorate a number of potential contributors to intradialytic hypotension when older dialysis technologies were routinely used. A lower dialyzer blood flow reduced acetate influx, decreased extracorporeal blood volume, and decreased the release of vasodilatory products of blood-membrane interactions. However, none of these considerations are applicable to current dialysis practice.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27082064     DOI: 10.1111/sdi.12486

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  3 in total

Review 1.  Continuous Renal Replacement Therapy: Who, When, Why, and How.

Authors:  Srijan Tandukar; Paul M Palevsky
Journal:  Chest       Date:  2018-09-25       Impact factor: 9.410

Review 2.  Hemodynamic Instability during Dialysis: The Potential Role of Intradialytic Exercise.

Authors:  Scott McGuire; Elizabeth Jane Horton; Derek Renshaw; Alofonso Jimenez; Nithya Krishnan; Gordon McGregor
Journal:  Biomed Res Int       Date:  2018-02-27       Impact factor: 3.411

Review 3.  Mechanisms for hemodynamic instability related to renal replacement therapy: a narrative review.

Authors:  Adrianna Douvris; Khalid Zeid; Swapnil Hiremath; Sean M Bagshaw; Ron Wald; William Beaubien-Souligny; Jennifer Kong; Claudio Ronco; Edward G Clark
Journal:  Intensive Care Med       Date:  2019-08-12       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.